Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04614350 · ClinicalTrials.gov registry record · Phase 4
Pilot Study for Healing and Safety Outcomes in Gingival Recession
A Phase 4 study, sponsored by McGuire Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT04614350 is a Phase 4 study that has completed, run by McGuire Institute. The registered enrollment target is 10 participants.
The verdict
NCT04614350, a Phase 4 study, has completed, sponsored by McGuire Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Prospective, randomized, within subjects-controlled design
Interventions
- BIOLOGICAL Markman Biologics Microsurfaced ADM
- BIOLOGICAL AlloDerm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04614350
The ClinicalTrials.gov registry entry for NCT04614350 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McGuire Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Markman Biologics Microsurfaced ADM is the first listed.
NCT04614350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04614350 about?
NCT04614350 is a clinical study titled "Pilot Study for Healing and Safety Outcomes in Gingival Recession". Prospective, randomized, within subjects-controlled design
What is the current status of trial NCT04614350?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2020-10-30. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04614350?
The interventions under investigation include: Markman Biologics Microsurfaced ADM (BIOLOGICAL), AlloDerm (BIOLOGICAL).
Who is sponsoring clinical trial NCT04614350?
This trial is sponsored by McGuire Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.